Cure: FDA approves tablet form of blood cancer treatment
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
August 5, 2022
The University of Cincinnati's John Byrd, MD, was featured in a Cure article on the FDA's approval of the tablet form of the drug Calquence to treat multiple blood cancers.
May 1, 2024
Yahoo News featured comments from the University of Cincinnati's Rekha Chaudhary in a story about rising rates of diagnoses and deaths from colorectal cancers among young people.
June 12, 2024
The University of Cincinnati Cancer Center announced a street in Uptown Cincinnati has been renamed Healing Way in anticipation of the opening of the Blood Cancer Healing Center.
May 29, 2024
The University of Cincinnati's Ann Romaker was featured in a Prevention article providing recommendations on the best earplugs for sleeping.
February 22, 2021
Shaina Horner, a clinical researcher in the Division of Infectious Diseases used her connections in the local Latinx community to help recruit a diverse population for the Moderna COVID-19 vaccine trial.
July 20, 2022
Yahoo News featured the University of Cincinnati's Jennifer Molano in an article about ways to boost your immunity during the BA.5 surge of COVID-19 cases.
November 7, 2023
The University of Cincinnati Cancer Center’s Vladimir Bogdanov found a new drug developed in his lab was effective at preventing pancreatic cancer growth and spread when combined with chemotherapy in lab tests.
August 30, 2022
The Guardian featured University of Cincinnati researcher Erica Birkley in an article on the effect of Americans halting COVID precautions on vulnerable populations.
October 20, 2022
New research out of the University of Cincinnati shows that a course of a hepatitis B vaccine provides complete protection for people with HIV. The UC research shows that a three-dose course of the hepatitis B vaccine HEPLISAV-B provides complete protection for people living with HIV who have never been vaccinated against or exposed to the hepatitis B virus (HBV).
March 22, 2023
Local 12 highlighted the University of Cincinnati's Bingfang Yan, who recently received a a $2.5 million National Institutes of Health grant to study how COVID-19 therapeutics can work together to create more effective and safe treatments for patients.